| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Autolus Therapeutics Plc's insiders have reduced their positions by a net 6,713 shares worth roughly $16K.
AUTL sits in the Biotechnology industry within the Healthcare sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 31.7K | - | - | |
| Dir | 31.7K | - | - | |
| Dir | 31.7K | - | - | |
| Dir | 31.7K | - | - | |
| Dir | 31.7K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Piccina Cintia | U.s. CCO &Country Gen Manager | Sale+OE | 6,713 | $2.34 | $15,681.57 | -33.6% |